BRAIN Biotech AG to build an international multi-niche enzyme and food ingredients champion
With the enzyme activities of the group focusing on food, beverage and healthcare, combined with BRAIN Biotech's strong scientific roots, the Group are well positioned to service global megatrends from the production of better and healthier foods to sustainable industrialisation.
Leading provider of integrated biotechnology solutions, BRAIN Biotech AG, announces at its fourth Capital Markets Day it's future strategy to drive performance towards its ambitious growth targets.
Included in the announcement to investors is the exciting news of building an international multi-niche enzyme and food ingredients champion. Consolidating the BRAIN group's Bioproducts businesses strengthens the integrated offering to customers as a multi-capability enzyme business.
Read more about the new organisational set up within the BRAIN Group, and the inspiring opportunities this delivers to our customers and partners, and to the wider environment in providing biotechnology solutions.
Highlights from BRAIN Biotech AG's Capital Markets Day:
- Strategy: building a successful international multi-niche enzyme and ingredients champion
- Performance made visible: new organisational setup
- Incubator: Akribion Genomics to focus on opportunities in therapeutics
- Upgraded new ambitious midterm targets
“BRAIN’s enzyme expertise starts with exceptional scientists and extends into application knowhow in multiple niches with the ability to manufacture in-house at large scale. We are a solutions provider of choice for our customers along the entire value chain.
